Henry Schein Profile


Odds of Distress

Analyze Filter    Fiscal Quarter End: December 31, 2019
Equity ratings for Henry Schein are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting September 10, 2019 and ending today December 9, 2019. Click here to learn more.

Henry Schein Profile

Next fiscal quarter end is expected on December 31, 2019. Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. The company was founded in 1932 and is headquartered in Melville, New York. Henry Schein operates under Medical Distribution classification in USA and is traded on BATS Exchange. It employs 19000 people. more
Henry Schein Fama & French Wholesale
Fama & French Classification
Henry Schein SEC Filings
Henry Schein SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameHenry Schein
CEOLonnie ShoffView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 4 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Healthcare, Medical Distribution
InstrumentUSA Stock View All
RegionNorth America
LocationNew York; U.S.A
Business Address135 Duryea Road
Foreign Associate  Austria
ExchangeBATS Exchange
CIK Number0001000228
Older SymbolHSICV
IndustryMedical Distribution
Phone631 843 5500
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 29, 2020
Most Recent QuarterSeptember 28, 2019
Last Fiscal Year EndDecember 29, 2018
Date Short InterestNovember 15, 2019
Henry Schein (HSIC) is traded on BATS Exchange in USA. It is located in 135 Duryea Road and employs 19,000 people. Henry Schein was previously known as Henry Schein and was traded on BATS Exchange under the symbol HSICV. Henry Schein is listed under Wholesale category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with current market capitalization of 10.06 B. Henry Schein conducts business under Healthcare sector and is part of Medical Distribution industry. The entity has 148.26 M outstanding shares of which 17.27 M shares are currently shorted by private and institutional investors with about 15.65 trading days to cover. HENRY SCHEIN INC currently holds about 84.92 M in cash with 1.17 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.57.
Check Henry Schein Probability Of Bankruptcy

Ownership Allocation (%)

Henry Schein Target Price Odds Analysis

Odds Below 68.68HorizonTargetOdds Above 68.68
88.19%30 days 68.68 11.68%
Based on normal probability distribution, the odds of Henry Schein to move above current price in 30 days from now is about 11.68 (This Henry Schein probability density function shows the probability of Henry Schein Stock to fall within a particular range of prices over 30 days) .

Henry Schein Top Holders

Henry Schein Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares17.3 M1.1 B
Longview Partners Guernsey LtdCommon Shares15.4 M978 M
View Henry Schein Diagnostics

Henry Schein Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Henry Schein Key Fundamentals

Henry Schein Against Markets

Did you try this?

Run Aroon Oscillator Now


Aroon Oscillator

Analyze current equity momentum using Aroon Oscillator and other momentum ratios
All  Next Launch Module

Henry Schein Upcoming and Recent Events

Henry Schein Company Earnings Announcements Dates

Upcoming Quarterly Earning ReportFebruary 19, 2020
Next Earnings ReportMay 5, 2020
Next Fiscal Quarter EndDecember 31, 2019
Next Fiscal Year EndFebruary 19, 2020
Last Quarter Report DateSeptember 30, 2019
Last Earning Anouncement DateDecember 31, 2018

Henry Schein Corporate Filings

Henry Schein SEC Reporting

Cost Associated with Exit or Disposal Activities
Financial Statements and Exhibits. Results of Operations and Financial Condition
Unclassified Corporate Event
Regulation FD Disclosure

Henry Schein Corporate Directors

Norman Matthews Independent Director
Philip Laskawy Lead Independent Director
Steven Paladino CFO, Executive VP and Executive Director
Please also check Risk vs Return Analysis. Please also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Search macroaxis.com